Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 5 - What They Never Told You

What's Next For Apple — Chamath Palihapitiya Fires Back: 'Don't Think They Have Any Chance Of Anything,' Dismisses Glasses And AI Hopes

Venture capitalist Chamath Palihapitiya has delivered a scathing critique of Apple Inc.'s (NASDAQ:AAPL) innovation prospects during an episode of the All-In podcast, bluntly stating the tech giant has no "chance of anything" when it comes to future breakthroughs.

With massive funding round and $31 billion valuation, Anduril is nearing the size of defense industry giants it wants to displace

With massive funding round and $31 billion valuation, Anduril is nearing the size of defense industry giants it wants to displace

Peter Thiel’s Founders Fund wrote its largest check ever into the company.

I run a $4.2B 9-year-old company that’s acquired 3 startups. M&A makes increasing sense for companies like mine—not just the Fortune 500

I run a $4.2B 9-year-old company that’s acquired 3 startups. M&A makes increasing sense for companies like mine—not just the Fortune 500

For a startup, M&A can be a multiplier of talent, market presence, and momentum—if it’s done right.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is Mastercard Stock Outperforming the S&P 500?

Mastercard has outperformed the S&P 500 over the past year and Wall Street analysts remain strongly bullish about the stock's prospects.

Dick's Sporting Goods just announced it’s buying Foot Locker for $2.4 billion in a move that could be the CEO's first major mistake

Dick's shares are plunging on news of the deal.

Do Wall Street Analysts Like Mastercard Stock?

Mastercard has continued to outperform the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

What to Expect From Mastercard’s Next Quarterly Earnings Report

Mastercard is set to report its first-quarter earnings next month, with analysts projecting modest, single-digit growth in its bottom line.

inkl

Read news from The Economist, FT, and more,
with one subscription

UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels

UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels

UnitedHealthcare Group is the best house in a rough neighborhood as its still a very profitable vertically integrated healthcare company, not just an insurer.

Morgan Stanley believed Google would rival Facebook if the search giant could beat Mark Zuckerberg to scooping up WhatsApp

Morgan Stanley believed Google would rival Facebook if the search giant could beat Mark Zuckerberg to scooping up WhatsApp

Zuckerberg worried about Google diving into social media, and created a competitive buffer around Meta through M&A, according to allegations in court documents.

Should You Buy These 2 Blue-Chip Dividend Stocks on the Tariff-Triggered Dip?

Should You Buy These 2 Blue-Chip Dividend Stocks on the Tariff-Triggered Dip?

These blue-chip stocks could be a good addition to a well-diversified portfolio.

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

Medicare Advantage's diagnosing tactics made insurers like UnitedHealthGroup $33 billion richer

Medicare Advantage's diagnosing tactics made insurers like UnitedHealthGroup $33 billion richer

Medicare Advantage plans are paid more for sicker members and less for healthier members, which provides an incentive for MA plans to report as many diagnoses as legitimately possible.

I tried using the Japanese concept of Ma to tackle my small cluttered kitchen and living space – it made me realize less really is more

I tried using the Japanese concept of Ma to tackle my small cluttered kitchen and living space – it made me realize less really is more

Small changes can make a big difference to the look and feel of a space

Homes & Gardens

How Is Mastercard's Stock Performance Compared to Other FinTech Stocks?

How Is Mastercard's Stock Performance Compared to Other FinTech Stocks?

Mastercard has significantly outperformed other fintech stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Beaten Down Healthcare Stocks Recovering in 2025

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

Mastercard Stock Outlook: Is Wall Street Bullish or Bearish?

Mastercard has outperformed the broader market over the past year, and Wall Street analysts remain bullish about the stock's future.

Nasdaq Futures Gain as Investors Weigh Big Tech Earnings, U.S. GDP Data and Apple Results in Focus

March Nasdaq 100 E-Mini futures (NQH25) are trending up +0.54% this morning as investors digested earnings reports from big U.S. tech companies.

Get all your
news in one place.

100's of premium titles.
One news app.

Nasdaq Futures Climb as Investors Weigh Big Tech Earnings, U.S. GDP Data and Apple Results in Focus

March Nasdaq 100 E-Mini futures (NQH25) are trending up +0.54% this morning as investors digested earnings reports from big U.S. tech companies.

Stocks Fall on Hawkish Fed Pause

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.24%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq...

What to Expect From Mastercard's Q4 2024 Earnings Report

Mastercard will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

How Cigna Remains at the Top of the Health Insurance Food Chain

The Cigna Group has been agile and nimbly navigating the trends in managed care as it unloaded its Medicare Advantage business before the storm hit its peers.

Problems with Medicare Advantage Plans Keep Mounting

Complaints about Medicare Advantage include denial of service and slow care approvals.

International Business Times UK

Wall Street Shares 4 AI Predictions and Top Stock Picks for 2025

Wall Street giants like Goldman Sachs and UBS think AI investments will continue to grow in the coming years as the AI revolution transitions to Phase 3 of companies monetising the technology to boost revenue streams.

Is This 'Strong Buy'-Rated Warren Buffett Stock a Buy Now?

This company may be well-established, but its growth story is far from over.

1 … 4 5 6 7

People

Mark Zuckerberg

Chamath Palihapitiya

Rebecca Shepherd

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

380,722 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play